25 February 2019 in Nature Genetics
8 June 2017 in PLOS Computational Biology
Genetic risk prediction is an important goal in human genetics research and precision medicine. Accurate prediction models will have great impacts on both disease prevention and early treatment strategies. Despite the identification of thousands of disease-associated genetic variants through genome wide association studies (GWAS), genetic risk prediction accuracy remains moderate for most diseases, which is largely due to the challenges in both identifying all the functionally relevant variants and accurately estimating their effect sizes in the presence of linkage disequilibrium. In this paper, we introduce AnnoPred, a principled framework that leverages diverse types of genomic and epigenomic functional annotations in genetic risk prediction for complex diseases. AnnoPred is trained using GWAS summary statistics in a Bayesian framework in which we explicitly model various functional annotations and allow for linkage disequilibrium estimated from reference genotype data. Compared with state-of-the-art risk prediction methods, AnnoPred achieves consistently improved prediction accuracy in both extensive simulations and real data. Genetic risk prediction plays a significant role in precision medicine. Accurate prediction models could have great impact on disease prevention and early treatment strategies. For example, mutations in BRCA1 and BRCA2 have been used to evaluate women’s breast cancer risk and as a guideline for early screening. However, genetic risk prediction models also present important challenges, including extreme high-dimensionality, limited access to and efficient computational methods for individual-level genotype data. To make use of rich GWAS summary statistics, we propose a novel method to address these challenges by integrating genomic functional annotations, which have been successfully applied in GWAS to generate biological insights. We demonstrate the improvement in accuracy in both extensive simulation studies and real data analysis of breast cancer, Crohn’s disease, celiac disease, rheumatoid arthritis and type-II diabetes.
9 June 2017 in PLOS Genetics
Accurate prediction of disease risk based on genetic factors is an important goal in human genetics research and precision medicine. Advanced prediction models will lead to more effective disease prevention and treatment strategies. Despite the identification of thousands of disease-associated genetic variants through genome-wide association studies (GWAS) in the past decade, accuracy of genetic risk prediction remains moderate for most diseases, which is largely due to the challenges in both identifying all the functionally relevant variants and accurately estimating their effect sizes. In this work, we introduce PleioPred, a principled framework that leverages pleiotropy and functional annotations in genetic risk prediction for complex diseases. PleioPred uses GWAS summary statistics as its input, and jointly models multiple genetically correlated diseases and a variety of external information including linkage disequilibrium and diverse functional annotations to increase the accuracy of risk prediction. Through comprehensive simulations and real data analyses on Crohn’s disease, celiac disease and type-II diabetes, we demonstrate that our approach can substantially increase the accuracy of polygenic risk prediction and risk population stratification, i.e. PleioPred can significantly better separate type-II diabetes patients with early and late onset ages, illustrating its potential clinical application. Furthermore, we show that the increment in prediction accuracy is significantly correlated with the genetic correlation between the predicted and jointly modeled diseases. Genetic risk prediction plays a significant role in precision medicine. Accurate prediction models could have great impact on disease prevention and treatment strategies. However, prediction accuracies for most complex diseases remain moderate mainly due to the challenges in identifying and quantifying the effects of genetic variants from millions of markers, limited access to individual-level genotype data, and lack of efficient computational methods. Up to now, most methods have been focused on predicting disease risk using data from a single trait. With the discovery of genetic correlations among many complex diseases, incorporating data of genetically correlated diseases could have the potential to increase prediction accuracy. Current statistical methods are not able to fully exploit the richness of these kinds of data to take into account the shared genetic architecture. To make use of commonly available GWAS summary statistics, we propose a novel method to address these challenges by jointly modeling genetically correlated diseases and integrating genomic functional annotations. We demonstrate the substantial improvement in accuracy in both extensive simulation studies and real data analysis of Crohn’s disease, celiac disease and type-II diabetes. Furthermore, we show that the increment in prediction accuracy is significantly correlated with the genetic correlation between the predicted and jointly modeled diseases.
1 January 1998 in IEEE Micro
Large RAM caches are generally used to speed up disk accesses. Such caches more effectively improve read performance than write performance, since write requests must be frequently written into disks to protect them from data loss or damage due to system failures. While Non-volatile RAM (NVRAM) caches can be used to improve write performance, large NVRAM caches are too expensive for many applications. This paper presents a new disk cache architecture called DCD, Disk Caching Disks. DCD takes the advantage of large data transfer sizes and uses inexpensive disk space to provide a high-performance, low-cost and reliable caching solution.
8 March 2016 in Biometrics